Hematology & Oncology Doctors in Meridian, ID Accepting Medicare

2 Hematology & Oncology doctors found. Showing 1 - 2

Dr. Stephanie Brooke Hodson, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2855 E Magic View Dr, Meridian, ID 83642 Phone: 208-888-8209    Fax: 208-888-8211

Silvana Z Bucur, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 520 S Eagle Rd, Lower Level, Meridian, ID 83642 Phone: 208-706-5651

News Archive

DASH eating plan reduces heart disease risk in African Americans: Study

A new study suggests yet another reason for Americans to abandon their current fatty diets in favor of one rich in fruits and vegetables and low in saturated fat. Choosing these healthier options appears to significantly reduce the long-term risk of heart disease in patients with mildly elevated blood pressure, particularly African Americans.

Tenet Healthcare withdraws from preliminary discussions regarding potential acquisition of Healthscope

Tenet Healthcare Corporation today announced it has withdrawn from preliminary discussions regarding a potential acquisition of the Australian private hospital operator Healthscope Limited. Due to the sequence of events associated with the acquisition process, including the premature disclosure of non-public information regarding Tenet's preliminary interest in Healthscope, Tenet has been unable to complete the work necessary to thoroughly convey to shareholders the potential value, including the inherent risks and opportunities, of this transaction.

Bariatric surgery may cut genetic risk for developing breast cancer

Women with a genetic predisposition for breast cancer were 2.5 times more likely to develop a malignancy than women with the same genetic risk who underwent bariatric or weight-loss surgery, according to a new study presented today by Cleveland Clinic Florida researchers at the 36th American Society for Metabolic and Bariatric Surgery Annual Meeting at ObesityWeek 2019.

Gene study may uncover regulatory network that influences development of cardiovascular disease

University of North Carolina researchers have discovered that disrupting a gene that acts as a regulatory switch to turn on other genes can keep blood vessels from forming and developing properly.

Roundup: Calif. insurer's Avastin decision; Kansas dental care; Gov. Brown vetoes nursing bill

Blue Shield of California will stop covering new Avastin prescriptions for breast cancer patients starting Oct. 17. Patients already on the drug will still be covered, and exceptions could be made for individual cases reviewed by a panel of cancer experts. The not-for-profit insurer cited an unprecedented vote by a U.S. Food and Drug Administration panel that found the drug was not effective enough against breast cancer to risk its potentially dangerous side effects.

Read more Medical News

› Verified 3 days ago